/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

M

Mircea Dediu

Clinical Emergency Hospital Bucharest(RO)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

88

Papers

11.9K

Citations

21

h-index

28

i10-index

Mircea Dediu is an academic researcher from Clinical Emergency Hospital Bucharest. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Lung Cancer Diagnosis and Treatment & Lung Cancer Research Studies. The author has an h-index of 21, co-authored 75 publications.

ORCID: 0000-0001-9151-6026

Research Topics

Lung Cancer Treatments and Mutations Lung Cancer Diagnosis and Treatment Lung Cancer Research Studies HER2/EGFR in Cancer Research Cancer therapeutics and mechanisms

Papers by this author

works

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

2019 · The Lancet · 3,270 citations

https://doi.org/10.1016/s0140-6736(18)32409-7

Tony Mok Yi‐Long Wu Iveta Kudaba Dariusz M. Kowalski

Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial

2015 · The Lancet Oncology · 472 citations

https://doi.org/10.1016/s1470-2045(15)00021-2

Nick Thatcher Fred R. Hirsch Alexander Luft Aleksandra Szczęsna

Long-Term and Low-Grade Safety Results of a Phase III Study (PARAMOUNT): Maintenance Pemetrexed Plus Best Supportive Care Versus Placebo Plus Best Supportive Care Immediately After Induction Treatment With Pemetrexed Plus Cisplatin for Advanced Nonsquamous Non–Small-Cell Lung Cancer

2014 · Clinical Lung Cancer · 36 citations

https://doi.org/10.1016/j.cllc.2014.06.007

Jean-Louis Pujol Luis Paz‐Ares Filippo de Marinis Mircea Dediu

Tyrosine kinase inhibitors in non-small cell lung and pancreatic cancer: the emerging role of erlotinib.

2007 · PubMed · 5 citations

Mircea Dediu D Median Aurelia Alexandru Georgeta Vremeş

My personal highlights of ESMO 2016

2017 · memo - Magazine of European Medical Oncology · 0 citations

https://doi.org/10.1007/s12254-017-0314-8

Mircea Dediu Armin Gerger Niklas Zojer Rupert Bartsch

Research topics

topics

Lung Cancer Treatments and Mutations

Lung Cancer Diagnosis and Treatment

Lung Cancer Research Studies

HER2/EGFR in Cancer Research

Cancer therapeutics and mechanisms

Chat about Author

Papers

Chat

Click to start Chat